Table 3. Clinical signs and symptoms at baseline and treatment outcomes.

	Total (n = 138)		Tanzania (n = 69)		Uganda (n = 69)		p-value
	n	%	n	%	n	%
Clinical signs & symptoms
Lymphadenopathy	27	19.6	7	10.1	20	29.0	0.0053
General body pain	132	95.7	69	100.0	63	91.3	0.0123
Headache	128	92.8	65	94.2	63	91.3	0.5114
Fever (≥37.5°C)	37	26.8	20	29.0	17	24.6	0.5643
Fever (>38.5°C)	4	2.9	0	0.0	4	5.8	0.0424
Joint pains	129	93.5	67	97.1	62	89.9	0.0847
Diarrhea	9	6.5	1	1.4	8	11.6	0.0158
Pruritus	21	15.2	4	5.8	17	24.6	0.0003
Oedema	40	29.0	26	37.7	14	20.3	0.0244
Dyspnoe	10	7.2	1	1.4	9	13.0	0.0086
Cough	27	19.6	8	11.6	19	27.5	0.0183
Tremor	54	39.1	43	62.3	11	15.9	0.0001
Hepatomegaly	25	18.1	4	5.8	21	30.4	0.0002
Splenomegaly	51	37.0	11	15.9	40	58.0	0.0001
Walking difficulties	75	54.3	35	50.7	40	58.0	0.3928
Abnormal movements	36	26.1	31	44.9	5	7.2	<0.0001
Sleeping disorder daytime	105	76.1	66	95.7	39	56.5	<0.0001
Sleeping disorder night time	88	63.8	64	92.8	24	34.8	<0.0001
Strange behaviour	25	18.1	15	21.7	10	14.5	0.2691
Disturbed appetite	120	87.0	60	87.0	60	87.0	1
Inactivity	100	72.5	57	82.6	43	62.3	0.0076
Speech impairment	16	11.6	6	8.7	10	14.5	0.2875
Aggressiveness	45	32.6	43	62.3	2	2.9	<0.0001
Treatment outcomes
Death	15	10.1	7	10.1	8	11.6	0.7845
Cure (parasitological & clinical)	123	89.1	62	89.9	61	88.4	0.7845